These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

893 related articles for article (PubMed ID: 12781359)

  • 1. Chk1 and Chk2 kinases in checkpoint control and cancer.
    Bartek J; Lukas J
    Cancer Cell; 2003 May; 3(5):421-9. PubMed ID: 12781359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
    Smith J; Tho LM; Xu N; Gillespie DA
    Adv Cancer Res; 2010; 108():73-112. PubMed ID: 21034966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo.
    Niida H; Murata K; Shimada M; Ogawa K; Ohta K; Suzuki K; Fujigaki H; Khaw AK; Banerjee B; Hande MP; Miyamoto T; Miyoshi I; Shirai T; Motoyama N; Delhase M; Appella E; Nakanishi M
    EMBO J; 2010 Oct; 29(20):3558-70. PubMed ID: 20834228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHK2 kinase--a busy messenger.
    Bartek J; Falck J; Lukas J
    Nat Rev Mol Cell Biol; 2001 Dec; 2(12):877-86. PubMed ID: 11733767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability.
    Chen Y; Poon RY
    Front Biosci; 2008 May; 13():5016-29. PubMed ID: 18508566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chk1 in the DNA damage response: conserved roles from yeasts to mammals.
    Chen Y; Sanchez Y
    DNA Repair (Amst); 2004; 3(8-9):1025-32. PubMed ID: 15279789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1.
    Yu Q; La Rose J; Zhang H; Takemura H; Kohn KW; Pommier Y
    Cancer Res; 2002 Oct; 62(20):5743-8. PubMed ID: 12384533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Chk2 protein kinase.
    Ahn J; Urist M; Prives C
    DNA Repair (Amst); 2004; 3(8-9):1039-47. PubMed ID: 15279791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage.
    Bahassi EM; Ovesen JL; Riesenberg AL; Bernstein WZ; Hasty PE; Stambrook PJ
    Oncogene; 2008 Jun; 27(28):3977-85. PubMed ID: 18317453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of Chk1 and Chk2 expression in colon cancer.
    Stawinska M; Cygankiewicz A; Trzcinski R; Mik M; Dziki A; Krajewska WM
    Int J Colorectal Dis; 2008 Dec; 23(12):1243-9. PubMed ID: 18679694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-talk between Chk1 and Chk2 in double-mutant thymocytes.
    Zaugg K; Su YW; Reilly PT; Moolani Y; Cheung CC; Hakem R; Hirao A; Liu Q; Elledge SJ; Mak TW
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3805-10. PubMed ID: 17360434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway.
    Falck J; Lukas C; Protopopova M; Lukas J; Selivanova G; Bartek J
    Oncogene; 2001 Sep; 20(39):5503-10. PubMed ID: 11571648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis.
    Falck J; Mailand N; Syljuåsen RG; Bartek J; Lukas J
    Nature; 2001 Apr; 410(6830):842-7. PubMed ID: 11298456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cell cycle, mitosis and therapeutic applications].
    Levy A; Albiges-Sauvin L; Massard C; Soria JC; Deutsch E
    Bull Cancer; 2011 Oct; 98(9):1037-45. PubMed ID: 21669563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells.
    Wang WJ; Wu SP; Liu JB; Shi YS; Huang X; Zhang QB; Yao KT
    Cancer Res; 2013 Feb; 73(3):1219-31. PubMed ID: 23269272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-cycle checkpoint kinases: checking in on the cell cycle.
    Walworth NC
    Curr Opin Cell Biol; 2000 Dec; 12(6):697-704. PubMed ID: 11063934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylator-induced, mismatch repair-dependent G2 arrest is activated through Chk1 and Chk2.
    Adamson AW; Beardsley DI; Kim WJ; Gao Y; Baskaran R; Brown KD
    Mol Biol Cell; 2005 Mar; 16(3):1513-26. PubMed ID: 15647386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of CHK1 and CHK2 homologues revealed a unique cross talk between ATM and ATR pathways in Neurospora crassa.
    Wakabayashi M; Ishii C; Inoue H; Tanaka S
    DNA Repair (Amst); 2008 Dec; 7(12):1951-61. PubMed ID: 18790091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status of p53 in human cancer cells does not predict efficacy of CHK1 kinase inhibitors combined with chemotherapeutic agents.
    Zenvirt S; Kravchenko-Balasha N; Levitzki A
    Oncogene; 2010 Nov; 29(46):6149-59. PubMed ID: 20729914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.